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The patient was a 43-year-old male whose chief complaint was syncope. Electro-
cardiography at the ﬁrst visit revealed escaped rhythm (38 bpm). After hospitalization
he developed reverse common atrial ﬂutter (AFL) and underwent catheter ablation.
After termination of atrial ﬂutter by ablation, sinus arrest was noted, allowing a diagnosis
of bradycardia-tachycardia syndrome, for which the patient underwent pacemaker implanta-
tion.
Twenty days after implantation, a marked elevation of atrial threshold was noted, despite
absence of a change in lead resistance or position, and atrial capturing was not possible even
at the maximum output (8 V/1.2ms). The cause remained unknown and the patient was
followed without active intervention. Atrial threshold normalized during the follow-up, but no
change was noted in lead resistance or position even at the time of normalization.
(J Arrhythmia 2011; 27: 63–67)
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Introduction
Theoretically speaking, AAI should suﬃce as a
pacing mode for patients with sick sinus syndrome
(SSS). However, some reports have demonstrated
that AAI was not suﬃcient because of the presence
of binodal disease (sinus dysfunction complicated by
disturbed atrioventricular conduction), changes in
the atrial lead position, elevation in threshold due to
drugs, etc.1–4) We recently encountered a case where
marked elevation of atrial threshold was noted after
pacemaker implantation and the exact cause for
such a change remained unclear. The case will be
presented in this paper.
Case report
The patient was a 43-year-old male whose chief
complaint was syncope. One day, he experienced
chest discomfort and cold sweating while on the
train. After getting oﬀ the train, he lost conscious-
ness while climbing stairs. Therefore was thus
carried to our hospital by ambulance.
Upon arrival at our hospital, a 12-lead ECG
revealed junctional escaped rhythm (38 bpm)
(Figure 1). P wave was absent. The junctional
rhythm heart rate changed to 70 bpm in response to
treatment with atropine sulfate, but P wave remained
absent. Metoprolol and disopyramide had been
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prescribed for him at another hospital to treat atrial
ﬂutter. His disease history included nothing note-
worthy. Regarding family history, it was found that
his father had died suddenly and his brothers had
been diagnosed as having arrhythmias (details are
unknown). Echocardiography disclosed no evident
abnormality. Coronary angiography revealed no
abnormal ﬁndings. An extracorporeal pacemaker
was implanted urgently and the patient was followed
closely thereafter. During the follow-up, atrial ﬂutter
(reverse common AFL) was noted. Therefore cath-
eter ablation was done after the patient’s consent to
treatment was obtained in writing (11 days after
admission).
A 5Fr 4-pole electrode catheter was inserted
into the right ventricular apex in the vicinity of the
His bundle, a 7Fr 20-pole electrode catheter was
inserted into the tricuspid annulus and a 6Fr 10-pole
electrode catheter was inserted via the subclavicular
vein into the coronary sinus. After an initial intra-
venous dose of heparin (3,000U), additional doses
of heparin (1,000U/dose) were given at intervals of
1 hour. The cycle length of tachycardia was 280ms.
Concealed entrainment was noted during pacing
from the isthmus. The patient was thus diagnosed
as having reverse common AFL. A 7Fr ablation
catheter was inserted via the femoral vein and linear
ablation was done from the tricuspid annulus to the
inferior vena cava inlet.
Just after termination of atrial ﬂutter by ablation,
sinus arrest lasted for about 30 seconds, allowing a
diagnosis of sick sinus syndrome (bradycardia-
tachcyardia syndrome) (Figure 2). Later, pacemaker
implantation was carried out on the basis of this
diagnosis. Nineteen days after admission (8 days
after ablation), the pacemaker (EnRhythm P1501
DR, Medtronic) was implanted into the left precor-
dial region. The mode was DDD, and MVP was set
to the ‘‘ON’’ position. The pacemaker was ﬁxed with
tined leads in the right atrial appendage (Medtronic
CapSure Z NOVUS 5554–53 cm) far from ablation
site and right ventricular apex (Medtronic CapSure Z
NOVUS 5054–58 cm). The lead resistance at the
time of implantation was 898 for the atrium and
1,157 for the ventricle. The threshold was 0.2
V/0.4ms for both atrium and ventricle. The sensing
measurement was 4.2mV for atrium and 15.3mV for
ventricle. When checked 7 days after implantation,
the lead resistance was 816 for atrium and 1,040
for ventricle, but the threshold was 1.0V/0.4ms for
atrium and 0.5V/0.4ms for ventricle. Spontaneous P
wave was absent. The atrial pacing rate was 100%
and the ventricular pacing rate was 0%. However,
when checked 20 days after implantation, both
the atrial and ventricular pacing rate were 100%
(Table 1). At that time, 12-lead ECG revealed no P
wave attributable to atrial pacing (Figure 3). But the
atrial lead resistance remained unchanged at 850
and chest X-ray also showed no change in the lead
position (Figure 4). Atrial capturing was not possible
even at the maximum output (8V/1.2ms), indicating
marked elevation in the atrial threshold. The cause
for elevated atrial threshold was unknown, and the
patient was followed closely. 30 days later, atrial
lead resistance remained unchanged at 904,
but atrial threshold had returned to normal (0.5
V/0.4ms). Then the atrial pacing/ventricular sens-
ing rate (ApVs) was 88.6%. After that, atrial
threshold remained within the normal range and
ApVs rose to 90% or higher.
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Figure 1 12-Lead ECG.
12-Lead ECG was taken during the ﬁrst visit
with a complaint of chest pain. Heart rate was
38/min. P wave was absent and junctional
rhythm was seen.
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Discussion
When atrium capturing was not possible even at
the maximum output on the 20th day after implan-
tation, we judged the problem was highly related
to atrial muscle because no change was seen in
X-ray ﬁndings or lead resistance. Based on this
judgment, the patient was followed closely without
reoperation. At ﬁrst, the author as a clinical
Table 1 Pacemaker data during outpatient visits.
Immediately after implantation, the atrial threshold was 0.2V, lead resistance was 898 and ApVs was 100%. Twenty days later,
lead resistance remained unchanged at 850, but atrial capture loss was seen, with ApVp being 100%.
A/V
Sense (mV)
A/V
Threshold (V)
A/V
Impedance () ApVs (%) ApVp (%)
07/11/09 4.2/15.3 0.2/0.2 898/1,157 100 ()
07/11/16 ()/15.9 1.0/0.5 816/1,040 100 0
07/11/29 ()/16.1 ()/0.5 850/1,250 0 100
07/12/02 ()/16.5 ()/0.5 810/1,180 0 100
07/12/10 4.5/17.6 0.5/0.5 848/1,200 17.6 75.4
07/12/20 ()/17.6 0.5/0.5 904/1,216 88.6 11.4
08/01/17 4.3/17.9 0.5/0.5 864/1,152 98.8 1.2
08/05/01 ()/17.9 0.5/0.5 808/1,072 99.2 0.8
08/08/20 ()/18.6 0.5/0.5 816/1,072 98.9 1.1
08/12/25 4.1/16.4 0.5/0.5 816/1,072 98.1 1.9
09/02/25 ()/16.4 0.5/0.5 816/1,072 99.1 0.9
Figure 2 Intracardiac eletrogram at the time of termination of reverse common AFL.
After hospitalization, the patient developed reverse common AFL. Intracardiac ECG revealed A wave in each Halo;
atrial standstill seemed unlikely. The cycle length of tachycardia was 280ms. Pacing from the isthmus showed concealed
entrainment. It was judged to be isthmus-dependent, and ablation for TVA-IVC was carried out. Tachycardia
discontinued in response to this treatment. But sinus arrest occurred when tachycardia discontinued. Therefore, diagnosis
of BTS (Bradycardia-Tachycardia syndrome) was made.
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engineering technologist considered that the problem
was probably associated with micro-dislodgement
or some abnormality in atrial muscle rather than
with defects of the pacemaker lead itself, because the
threshold rose without any change of lead resistance
or lead position assessed by X-ray, although meas-
urement in a unipolar mode was not possible for the
EnRhythm pacemaker. But involvement of micro-
dislodgement in seemed unlikely, because no asso-
ciated inﬂammatory reaction was noted, and atrial
capturing was not possible even at the maximum
output. During the period, no drugs were used which
could have been responsible. Although the exact
cause remains unidentiﬁed, it seems possible that
some reversible change took place in the atrial
muscle.
We could not ﬁnd any published reports of similar
cases.
Conclusion
If clinical engineering technologists face a prob-
lem such as that described herein with patients after
pacemaker implantation, they should judge whether
the problem is related to the pacemaker system or the
heart, instead of ﬁrst asking physicians about the
possibility of reoperation. They should give their
advice to the physicians based on such a judgment.
Pacemaker implantation 20 days after implantation
Figure 4 Chest X-ray.
Chest X-ray, taken at the time of pacemaker implantation and 20 days later, revealed no dislodgement of the leads.
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Figure 3 Atrial pacing failure (20 days
after implantation).
When the pacemaker was checked 20 days after
implantation, i.e., when the patient complained
of chest pain, ApVs was 100%. At that time,
atrial lead resistance was 850 and no change
was seen on chest X-ray, but the threshold rose,
making it impossible to capture the atrium even
at the maximum output (8V/1.2ms).
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